Related Experiment Video
Updated: Jul 15, 2026

08:44
Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells
Published on: June 22, 2013
13.6K
Safe and Noninvasive Method for Generating Induced Mesenchymal Stem Cells from Urinary Epithelial Cells
Sheeja Rajasingh1, Hemanathan Vembuli1, Selene Perales1
1Department of Bioscience Research, College of Dentistry, University of Tennessee Health Science Center, Memphis, TN, USA.
Methods in Molecular Biology (Clifton, N.J.)
|August 6, 2024
Summary
This study introduces a noninvasive method to generate induced pluripotent stem cells (iPSCs)-derived mesenchymal stem cells (iMSCs) from urinary epithelial cells (UECs). This offers a scalable, autologous source for regenerative therapies.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Urology
Background:
- Mesenchymal stem cells (MSCs) show therapeutic potential for tissue regeneration but face scalability and storage limitations.
- Induced pluripotent stem cells (iPSCs) offer an alternative to embryonic stem cells, avoiding ethical concerns and enabling autologous applications.
- Urinary epithelial cells (UECs) present a readily accessible, noninvasive source for generating iPSCs.
Purpose of the Study:
- To develop a straightforward, noninvasive method for generating autologous iPSCs-derived MSCs (iMSCs) from UECs.
- To establish a scalable and reliable source of high-quality iMSCs for regenerative medicine.
- To overcome limitations associated with traditional MSC sources.
Main Methods:
- Isolation of UECs from urine samples.
- Reprogramming UECs into induced pluripotent stem cells (UE-iPSCs).
- Differentiation of UE-iPSCs into iMSCs.
Main Results:
- Successful generation of autologous iMSCs from UECs via a noninvasive procedure.
- Demonstrated significant replicative and differentiation potential of the generated iMSCs.
- Established a viable alternative to traditional MSC sources.
Conclusions:
- The developed method provides a promising, noninvasive approach for producing autologous iMSCs from UECs.
- This technique enhances the potential for scalable and ethically sound regenerative therapies.
- UE-derived iMSCs hold significant promise for treating various diseases and injuries.
Keywords:
DifferentiationInduced pluripotent stem cellsMesenchymal stem cellsPluripotent genesStem cells
